Market Place
Sourcing Support
CRISPR Therapeutics to Present at Jefferies London Conference
14 Nov 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics to Present at Guggenheim Healthcare Conference
07 Nov 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics Provides Q3 2024 Business & Financial Update
05 Nov 2024 //
GLOBENEWSWIRE
UK`s NHS To Roll Out Vertex/CRISPR Gene Therapy For Rare Blood Disorder
08 Aug 2024 //
REUTERS
CRISPR Therapeutics Reports Q2 2024 Results And Business Update
05 Aug 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
29 May 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
23 May 2024 //
GLOBENEWSWIRE
Tessera unveils promising in vivo gene editing for sickle cell in #ASGCT24
10 May 2024 //
ENDPTS
CRISPR Therapeutics At BofA Healthcare Conference
09 May 2024 //
GLOBENEWSWIRE
With 64 centers activated, bluebird is ready to grow Lyfgenia
09 May 2024 //
FIERCE PHARMA
CRISPR New In Vivo Editing Programs, ASGCT Presentation
08 May 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics Q1 2024 Results, Business Update
08 May 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics Oral Presentation At ASGCT 2024
22 Apr 2024 //
GLOBENEWSWIRE
CRISPR to Present at the Annual Needham Virtual Healthcare Conference
03 Apr 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics to Present at the ASGCT 2024 Annual Meeting
01 Apr 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
13 Mar 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 2024 //
GLOBENEWSWIRE
CRISPR Therapeutics to Present at Citi 2024 Virtual Oncology Leadership Summit
15 Feb 2024 //
PRESS RELEASE
CRISPR Therapeutics Announces $280 Million Registered Direct Offering
13 Feb 2024 //
GLOBENEWSWIRE
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY
13 Feb 2024 //
GLOBENEWSWIRE
Former CRISPR Tx CMO finds new home at Takeda
02 Feb 2024 //
FIERCE BIOTECH
US FDA approves Vertex/CRISPR gene therapy for an inherited blood disorder
17 Jan 2024 //
REUTERS
CRISPR Tx director: It’s ‘still early days’ on sealing new deals
10 Jan 2024 //
FIERCE BIOTECH
CRISPR Therapeutics Highlights Strategic Priorities and 2024 Outlook
08 Jan 2024 //
GLOBENEWSWIRE
Vertex cuts ties to CRISPR’s type 1 diabetes stem cell therapy
08 Jan 2024 //
FIERCE BIOTECH
CRISPR to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
High-profile Casgevy launch could face supply hitches: doctor
21 Dec 2023 //
FIERCE PHARMA
CRISPR Tx CMO resigns just 6 days after Casgevy`s FDA approval
20 Dec 2023 //
FIERCE BIOTECH
Europe lines up first CRISPR therapy approval
15 Dec 2023 //
ENDPTS
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
09 Dec 2023 //
PR NEWSWIRE
CRISPR Tx cuts cancer programs, expands into autoimmune disease
05 Dec 2023 //
FIERCE BIOTECH
Vertex/CRISPR selects RoslinCT as CDMO for Casgevy
29 Nov 2023 //
BIOPROCESS INTERNATIONAL
CRISPR Therapeutics laid off staff a week after positive AdComm
22 Nov 2023 //
FIERCE BIOTECH
Vertex and CRISPR Therapeutics Announce Authorization of CASGEVY
16 Nov 2023 //
BUSINESSWIRE
CRISPR Therapeutics Announces Preclinical Data at the AHA
06 Nov 2023 //
GLOBENEWSWIRE
CRISPR Therapeutics Reports Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
CRISPR Therapeutics Trading Halted Today
31 Oct 2023 //
GLOBENEWSWIRE
CRISPR Announces Completion of Committee Meeting for Exagamglogene Autotemcel
31 Oct 2023 //
GLOBENEWSWIRE
CRISPR-Vertex gene editing 1st gets narrow review by FDA panel
28 Oct 2023 //
FIERCE BIOTECH
CRISPR on hunt for pipeline partners and enticing delivery tech
19 Oct 2023 //
FIERCE BIOTECH
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
16 Oct 2023 //
GLOBENEWSWIRE
CRISPR Therapeutics to Present at the SITC 38th Annual Meeting
27 Sep 2023 //
GLOBENEWSWIRE
CRISPR Therapeutics Announces Leadership Transition
07 Sep 2023 //
GLOBENEWSWIRE
CRISPR Therapeutics to Participate in Citi`s 18th Annual Biopharma Conference
30 Aug 2023 //
GLOBENEWSWIRE
CRISPR Therapeutics Reports Second Quarter 2023 Financial Results
07 Aug 2023 //
GLOBENEWSWIRE
CRISPR to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
13 Jun 2023 //
GLOBENEWSWIRE
CRISPR Therapeutics Provides Business Update and Reports 1Q 2023 FYR
08 May 2023 //
GLOBENEWSWIRE
CRISPR unicorn Mammoth backs off diagnostics research, laying off 35
08 May 2023 //
ENDPTS
Maria Fardis ends a two-year CEO hiatus; More leadership turnover at Galapagos
05 May 2023 //
ENDPTS
Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC
03 May 2023 //
BUSINESSWIRE
CRISPR Therapeutics to Participate Upcoming Investor Conferences
02 May 2023 //
GLOBENEWSWIRE
Vertex, bluebird SCD gene therapies can cost $1.9M
13 Apr 2023 //
FIERCE PHARMA
CRISPR Therapeutics to Participate in Needham 22nd Annual Healthcare Conference
13 Apr 2023 //
GLOBENEWSWIRE
Vertex/CRISPR`s gene editing therapy cost effective at $1.9 million
12 Apr 2023 //
REUTERS
CRISPR Announces Formation of Scientific Advisory Board with Rodolphe Barrangou
10 Apr 2023 //
BUSINESSWIRE
CRISPR QC Co-founder Kiana Aran Makes Inc.’s 2023 Female Founders List
05 Apr 2023 //
BUSINESSWIRE
Vertex & CRISPR Complete Submission of Rolling BLA for exa-cel Beta Thalassemia
03 Apr 2023 //
BUSINESSWIRE
CRISPR Therapeutics Announces Departure of Board Member
29 Mar 2023 //
GLOBENEWSWIRE
In search of new way to deliver gene editors, CRISPR pioneer turns to molecular syringes
29 Mar 2023 //
ENDPTS
Vertex doubles down on CRISPR Tx and diabetes in new $100M deal
28 Mar 2023 //
FIERCE BIOTECH
